Compare MLAB & BDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLAB | BDN |
|---|---|---|
| Founded | 1982 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Real Estate Investment Trusts |
| Sector | Industrials | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 461.9M | 535.0M |
| IPO Year | 1995 | 1995 |
| Metric | MLAB | BDN |
|---|---|---|
| Price | $105.89 | $3.02 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 4 |
| Target Price | ★ $94.00 | $3.50 |
| AVG Volume (30 Days) | 85.7K | ★ 2.1M |
| Earning Date | 05-27-2026 | 04-22-2026 |
| Dividend Yield | 0.67% | ★ 10.67% |
| EPS Growth | ★ 99.24 | 9.65 |
| EPS | ★ 1.95 | N/A |
| Revenue | N/A | ★ $484,454,000.00 |
| Revenue This Year | $6.07 | $12.96 |
| Revenue Next Year | $5.41 | N/A |
| P/E Ratio | $53.24 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $59.63 | $2.47 |
| 52 Week High | $128.55 | $4.63 |
| Indicator | MLAB | BDN |
|---|---|---|
| Relative Strength Index (RSI) | 65.71 | 57.13 |
| Support Level | $69.73 | $2.91 |
| Resistance Level | $106.28 | $3.14 |
| Average True Range (ATR) | 4.43 | 0.11 |
| MACD | 0.17 | 0.01 |
| Stochastic Oscillator | 92.48 | 71.67 |
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
Brandywine Realty Trust engaged in the acquisition, development, redevelopment, ownership, management, and operation of a portfolio of office, life science/lab, residential, and mixed-use properties. The company owned and managed properties within five segments. The Philadelphia CBD segment includes properties located in the City of Philadelphia in Pennsylvania. The Pennsylvania Suburbs segment includes properties in Chester, Delaware and Montgomery counties in the Philadelphia suburbs. The Austin, Texas segment includes properties in the City of Austin, Texas. The Metropolitan Washington, D.C. segment includes properties in Northern Virginia, Washington, D.C. and Southern Maryland. The Other segment includes properties in Camden County, New Jersey and New Castle County, Delaware.